| P50 | author | Colin K. Combs | Q113460560 |
| P2093 | author name string | Shanshan Li | |
| | Angela M Floden | |
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| | Inflammation and Alzheimer's disease | Q28138617 |
| | Heteromeric NMDA receptors: molecular and functional distinction of subtypes | Q28182183 |
| | Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pat | Q28507531 |
| | Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function. | Q31832269 |
| | beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. | Q31840031 |
| | Microglial secreted cathepsin B induces neuronal apoptosis. | Q32134547 |
| | Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. | Q33900383 |
| | Cytokines in CNS disorders: neurotoxicity versus neuroprotection. | Q34015531 |
| | Evaluation of memantine for neuroprotection in dementia | Q34074926 |
| | Implications of the kynurenine pathway and quinolinic acid in Alzheimer's disease | Q34978935 |
| | The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock | Q35025367 |
| | Tumor necrosis factor-alpha at the crossroads of neuronal life and death during HIV-associated dementia | Q35197030 |
| | Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis | Q35606094 |
| | Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition | Q35883550 |
| | Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease | Q36367437 |
| | RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide | Q36438395 |
| | Excitatory amino acids and Alzheimer's disease | Q38301056 |
| | 'Footprinting' proteins on DNA with peroxonitrous acid | Q40407253 |
| | Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives | Q40896821 |
| | Amyloid beta and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia | Q40897569 |
| | Alpha-MSH peptides inhibit production of nitric oxide and tumor necrosis factor-alpha by microglial cells activated with beta-amyloid and interferon gamma | Q40929097 |
| | Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins | Q40977784 |
| | Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide | Q41082551 |
| | Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells | Q41086360 |
| | Elevated circulating tumor necrosis factor levels in Alzheimer's disease | Q41145103 |
| | Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression. | Q42439235 |
| | Frequency of stages of Alzheimer-related lesions in different age categories | Q42445469 |
| | The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition | Q42494371 |
| | 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo | Q42551195 |
| | NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology | Q42551259 |
| | Reduction of potassium currents and phosphatidylinositol 3-kinase-dependent AKT phosphorylation by tumor necrosis factor-(alpha) rescues axotomized retinal ganglion cells from retrograde cell death in vivo. | Q43540470 |
| | Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity | Q43578149 |
| | Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease | Q43736972 |
| | Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42- and lipopolysaccharide-activated microglia. | Q43972731 |
| | Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). | Q44240005 |
| | Involvement of protein kinase C in glutamate release from cultured microglia. | Q44288422 |
| | Memantine in moderate-to-severe Alzheimer's disease | Q44388745 |
| | Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. | Q44418529 |
| | Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells. | Q44569658 |
| | Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide. | Q44663969 |
| | Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. | Q44702932 |
| | Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial | Q44735780 |
| | Memantine enhances autonomy in moderate to severe Alzheimer's disease | Q44905400 |
| | Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide. | Q44968991 |
| | Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice | Q45079664 |
| | Noradrenaline up-regulates the neuronal and the inducible nitric oxide synthase isoforms in magnocellular neurons of rat brain slices | Q45115799 |
| | Role of inducible nitric oxide synthase in N-methyl-d-aspartic acid-induced strio-nigral degeneration | Q45143936 |
| | The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain | Q46298050 |
| | Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. | Q47868031 |
| | Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways | Q48110528 |
| | Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia | Q48121615 |
| | beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease | Q48205438 |
| | Metalloporphyrins are potent inhibitors of lipid peroxidation | Q48226744 |
| | Ischemic and excitotoxic brain injury is enhanced in mice lacking the p55 tumor necrosis factor receptor | Q48331119 |
| | Potentiation of N-methyl-D-aspartate-mediated neurotoxicity by immunostimulated murine microglia | Q48373300 |
| | Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation. | Q48380256 |
| | The transcription factor NF-kappaB mediates increases in calcium currents and decreases in NMDA- and AMPA/kainate-induced currents induced by tumor necrosis factor-alpha in hippocampal neurons | Q48478208 |
| | Tumor necrosis factor enhancement of transient outward potassium currents in cultured rat cortical neurons | Q48549443 |
| | Activation of NF-kappaB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of manganese superoxide dismutase and suppression of peroxynitrite production and protein tyrosine nitration | Q48615547 |
| | Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways. | Q48635220 |
| | Widespread peroxynitrite-mediated damage in Alzheimer's disease | Q48728343 |
| | Diurnal variation of TNF alpha in the rat brain | Q48768281 |
| | Age- and concentration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid | Q48857056 |
| | 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia | Q49105194 |
| | Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain | Q53201329 |
| | Alzheimer's congress. Drug shows promise for advanced disease. | Q53237020 |
| | Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. | Q53324593 |
| | Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD. | Q54091326 |
| | Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling | Q58435118 |
| | A High Plasma Concentration of TNF- Is Associated With Dementia in Centenarians | Q59326375 |
| | Metabolic Fate of Peroxynitrite in Aqueous Solution | Q61906307 |
| | Peroxynitrite formation from macrophage-derived nitric oxide | Q67505344 |
| | Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite | Q67568058 |
| | Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide | Q67913773 |
| | Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels | Q69358445 |
| | beta-Amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity | Q71473378 |
| | Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-D-aspartate receptor subunits | Q71804134 |
| | Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures | Q72130001 |
| | Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis | Q72458408 |
| | 2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation | Q72459975 |
| | CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase | Q73066505 |
| | NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro | Q73258586 |
| | Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity | Q73471984 |
| | Na+-dependent high-affinity glutamate transport in macrophages | Q73755966 |
| | Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide | Q78060771 |
| | Inducible form of nitric oxide synthase expression in rat cortical neuronal cells in vitro | Q80533035 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microglia | Q1622829 |
| P304 | page(s) | 2566-2575 | |
| P577 | publication date | 2005-03-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors | |
| P478 | volume | 25 | |